Back to Search
ZEEV ESTROV, M.D.
M.D.
Medical Oncology Physician
NPI: 1851491104Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
K0738(TX)
Research & Publications (20)
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.
PMID 19340529·Int J Hematol·2009
8-other
Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells.
PMID 12689943·Blood·2003
8-other
Ex vivo expansion of apheresis-derived peripheral blood hematopoietic progenitors.
PMID 11948700·J Clin Apher·2002
4-observational
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.
PMID 19679351·Leuk Res·2010
4-observational
Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.
PMID 18190591·Int J Lab Hematol·2009
8-other
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.
PMID 19383925·Cancer Res·2009
8-other
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.
PMID 18715642·Leuk Res·2009
8-other
Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin.
PMID 19075265·J Clin Oncol·2009
8-other
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome.
PMID 19458051·Clin Cancer Res·2009
8-other
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
PMID 19439093·J Hematol Oncol·2009
3-trial
Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.
PMID 19458629·Leukemia·2009
7-preclinical
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation.
PMID 18245540·Clin Cancer Res·2008
8-other
Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.
PMID 18230792·J Natl Cancer Inst·2008
3-trial
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.
PMID 18565853·Blood·2008
2-rct
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies.
PMID 18473351·Cancer·2008
3-trial
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax).
PMID 18451169·Cancer Res·2008
7-preclinical
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.
PMID 18334676·Blood·2008
3-trial
Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells.
PMID 18347134·Mol Cancer Ther·2008
8-other
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.
PMID 18495956·Blood·2008
3-trial
The JAK kinase inhibitor CP-690,550 suppresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation.
PMID 18482053·Cancer Sci·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1851491104
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile